Filters

Mouse Monoclonal Anti-Zika Virus NS1 Protein (African) #2-Biotinylated

Mouse Monoclonal Anti-Zika Virus NS1 Protein (African) #2-Biotinylated size: 100 μL 623

Supplier ADI
Price 623
Size 100 μL
ELISA kit stock availabilityAvailable In Stock
ELISA's descriptionMouse Monoclonal Anti-Zika Virus NS1 Protein (African) #2-Biotinylated
CategoryPrimary Antibodies
S typeMonoclonal
Antibody's host isMouse
PurificationAffinity purified
About Each murine monoclonal anibody has his own affinity specific for the clone, Mouse monoclonal antibodies are purified protein A or G and can be conjugated to FITC for flow cytometry or FACS and can be of different isotypes, Monoclonals of this antigen are available in different clones
Test A/J, BALB/c, Mouse are mature after 40 days for females and 55 days for males, SCID while the CD-1 is outbred as strain, The female mice are pregnant only 20 days and can give birth to 10 litters of 6-8 mice a year, Transgenic, congenic and inbread strains are known for C57BL/6, knock-out, Mouse , mice from the Mus musculus species are used for production of mouse monoclonal antibodies or mabs and as research model for humans in your lab, or 
Latin nameMus musculus
Gene targetMonoclonal Zika Virus NS1 Protein (African) #2-Biotinylated
Short nameMouse Monoclonal Anti-Zika Virus NS1 Protein (African) #2-Biotinylated
Technique Monoclonals or monoclonal antibodies, mouses, Mouse
Species Mouses, Viruses, Virus
Alternative nameMouse monoclonal antibody to-ZIKV Virus NS1 Protein (African) #2-Biotinylated
Alternative techniquemurine
Identity 9644
Gene PTPN11
Long gene name non-receptor type 11 , protein tyrosine phosphatase
Synonyms gene NS1
Synonyms gene name Noonan syndrome 1
Synonyms BPTP3 SH-PTP2 SHP-2 PTP2C SHP2
Locus 12q24, 13
Discovery year 1993-03-03
GenBank acession D13540
Entrez gene record 5781
Pubmed identfication 7894486 1280823
Classification Protein tyrosine phosphatases, non-receptor type SH2 domain containing
Havana BLAST/BLAT OTTHUMG00000134334
Locus Specific Databases LRG_614

Subscribe to our Newsletter